News

Protagonist Announces Nomination of PN-477, an Oral and Injectable GLP-1R, GIPR, and GCGR Triple Agonist Peptide Development Candidate for Obesity
A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...
Glass Lewis Endorses All Five Askeladden Nominees; Askeladden Comments on Resignation of CEO Greg Woods
Glass Lewis recommends FOR all five Askeladden Nominees, citing “detailed, coherent, and realistic strategy” and ...
Network-1 Commences Patent Litigation Against Samsung Entities
NEW CANAAN, CT / ACCESS Newswire / June 30, 2025 / Network-1 T, Inc. (NYSE:NTIP) announced today that it has initiated patent ...
Amaze Surpasses 200 Million Storefront Visits, Solidifying Leadership in Rapidly Expanding Creator Economy
Fueled by Over 13 Million Global Creators, Milestone Reflects Platform Growth, Strategic Positioning, and Accelerating Creator Monetization NEWPORT BEACH, CA / ACCESS Newswire / June 30, 2025 / Amaze ...